Moolec Science logo

Moolec Science(NASDAQ) MLECW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 Year-98%
1 Year-20%
1 Month-35%
$0.01
+0.00%
+0.00Today
Moolec Science last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-12
Moolec Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-32.89%USD 0.012026-10-05
1 month-34.64%USD 0.022026-09-11
3 month-35.48%USD 0.022026-07-14
Year to date+72.41%USD 0.012025-12-31
1 year-20%USD 0.012025-10-10
3 year-75.9%USD 0.042023-10-13
5 year-98.04%USD 0.512021-10-13
Since inception-99.09%USD 1.102021-03-02

Moolec Science Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.83M

Net Income (TTM)

-$8.28M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Price

$0.01

Volume

37

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.16

Estimated Earnings Date

May 28, 2026

MLECW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moolec Science

Moolec Science S.A. is a pioneering ingredient company that focuses on producing animal proteins within plants through an innovative technique known as Molecular Farming. This disruptive approach positions the company at the forefront of the alternative protein industry, leveraging the agricultural strengths of key crops like soybeans and peas.

Products and Services
  • Animal proteins generated through Molecular Farming
  • Innovative ingredients for food and feed applications
  • Research and development in biotechnology and agriculture
Growth Outlook
  • Projected growth in the alternative protein market, expected to reach $27 billion by 2027
  • Strategic partnerships with agricultural stakeholders to enhance production capabilities
  • Expansion into new markets across the U.S., Europe, and South America
Financial Highlights
  • Recent quarterly revenue of $2.64 million, showing a significant increase
  • Trailing twelve months (TTM) revenue of $10.5 million, indicating growth potential
  • Operating expenses of $4.7 million in the latest quarter, reflecting ongoing investment in R&D
Moolec Science S.A. operates in the biotechnology sector, emphasizing sustainable and innovative solutions for protein production. The company's unique approach to integrating animal proteins into plants not only addresses the growing demand for alternative protein sources but also aligns with global sustainability goals. Established in 2008 and headquartered in Luxembourg, Moolec Science is well-positioned to capitalize on the increasing consumer shift towards plant-based diets. The recent financial performance highlights a commitment to growth, with substantial investments in research and development aimed at enhancing product offerings and market reach. As the alternative protein market continues to expand, Moolec Science S.A. stands out as a key player with the potential for significant impact and returns.
AI Generated • Oct 4, 2026

Industry

Food Products

Headquarters

Grand Cayman, GT KY1-9009, KY

MLECW Financials

Key Financial Metrics (TTM)

Gross Margin

34.17%

Operating Margin

-3.14%

Net Income Margin

-33.41%

Return on Equity

376.84%

Return on Capital

-5.79%

Return on Assets

-54.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

37

Avg. Volume

18.77K

Financials (TTM)

Gross Profit

-$639.50K

Operating Income

-$9.14M

EBITDA

-$5.21M

Operating Cash Flow

-$5.70M

Capital Expenditure

-$419.96K

Free Cash Flow

-$6.12M

Cash & ST Invst.

$1.08M

Total Debt

$66.48M

Moolec Science Performance Analysis

Moolec Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-27.8%
Q12024-09-302.2%
Q22024-12-3169.7%
Q22025-12-31N/A
Moolec Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-75.0%
Q12024-09-3028.6%
Q22024-12-31-20.0%
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$2.64M

+948.3%

Gross Profit

-$674.37K

-7285.5%

Gross Margin

-25.52%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

52

N/A

Net Income

-$2.43M

-36.1%

EBITDA

-$1.15M

+33.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$1.08M

-74.7%

Total Debt

$66.48M

+378.6%

Accounts Receivable

$3.97M

+128.2%

Inventory

$3.99M

+930.1%

Long Term Debt

$12.03M

+10.3%

Short Term Debt

$54.45M

+1723.2%

Return on Assets

-54.45%

N/A

Return on Invested Capital

33.43%

N/A

Free Cash Flow

-$1.19M

+70.6%

Operating Cash Flow

-$890.48K

+78.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRSNNeuroSense Therapeutics Ltd.
$3.49+0.29%
VIVSVivoSim Labs, Inc.
$0.17+0.11%
CYCNCyclerion Therapeutics, Inc.
$23.52+0.00%
TCRTAlaunos Therapeutics, Inc.
$3.03+188.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About MLECW

What is the current price of Moolec Science?

Moolec Science is trading at $0.01 per share.

What is the 52-week range for Moolec Science?

Over the past 52 weeks, Moolec Science has traded between $0.00 and $0.16.

How much debt does Moolec Science have?

Moolec Science total debt is unavailable.

How much cash does Moolec Science have on hand?

Moolec Science does not have cash on hand data available.

What is Moolec Science’s dividend yield?

Moolec Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.